142
Views
0
CrossRef citations to date
0
Altmetric
Research Articles

Lysine acetyltransferase KAT2A modulates ferroptosis during colorectal cancer development

, , , , , & show all
Pages 437-444 | Received 20 Oct 2023, Accepted 30 Dec 2023, Published online: 23 Jan 2024

References

  • Phipps O, Brookes MJ, Al-Hassi HO. Iron deficiency, immunology, and colorectal cancer. Nutr Rev. 2021;79(1):88–97. doi: 10.1093/nutrit/nuaa040.
  • Dekker E, Tanis PJ, Vleugels JLA, et al. Colorectal cancer. Lancet. 2019;394(10207):1467–1480. doi: 10.1016/S0140-6736(19)32319-0.
  • Modest DP, Pant S, Sartore-Bianchi A. Treatment sequencing in metastatic colorectal cancer. Eur J Cancer. 2019;109:70–83. doi: 10.1016/j.ejca.2018.12.019.
  • Piawah S, Venook AP. Targeted therapy for colorectal cancer metastases: a review of current methods of molecularly targeted therapy and the use of tumor biomarkers in the treatment of metastatic colorectal cancer. Cancer. 2019;125(23):4139–4147. doi: 10.1002/cncr.32163.
  • Biller LH, Schrag D. Diagnosis and treatment of metastatic colorectal cancer: a review. JAMA. 2021;325(7):669–685. doi: 10.1001/jama.2021.0106.
  • Miao Y, Chen Y, Xue F, et al. Contribution of ferroptosis and GPX4's dual functions to osteoarthritis progression. EBioMedicine. 2022;76:103847. doi: 10.1016/j.ebiom.2022.103847.
  • Forcina GC, Dixon SJ. GPX4 at the crossroads of lipid homeostasis and ferroptosis. Proteomics. 2019;19(18):e1800311. doi: 10.1002/pmic.201800311.
  • Seibt TM, Proneth B, Conrad M. Role of GPX4 in ferroptosis and its pharmacological implication. Free Radic Biol Med. 2019;133:144–152. doi: 10.1016/j.freeradbiomed.2018.09.014.
  • Friedmann Angeli JP, Schneider M, Proneth B, et al. Inactivation of the ferroptosis regulator Gpx4 triggers acute renal failure in mice. Nat Cell Biol. 2014;16(12):1180–1191. doi: 10.1038/ncb3064.
  • Ye Y, Chen A, Li L, et al. Repression of the antiporter SLC7A11/glutathione/glutathione peroxidase 4 axis drives ferroptosis of vascular smooth muscle cells to facilitate vascular calcification. Kidney Int. 2022;102(6):1259–1275. doi: 10.1016/j.kint.2022.07.034.
  • Koppula P, Zhuang L, Gan B. Cystine transporter SLC7A11/xCT in cancer: ferroptosis, nutrient dependency, and cancer therapy. Protein Cell. 2021;12(8):599–620. doi: 10.1007/s13238-020-00789-5.
  • Ding Y, Chen X, Liu C, et al. Identification of a small molecule as inducer of ferroptosis and apoptosis through ubiquitination of GPX4 in triple negative breast cancer cells. J Hematol Oncol. 2021;14(1):19. doi: 10.1186/s13045-020-01016-8.
  • Sun L, Zhang H, Gao P. Metabolic reprogramming and epigenetic modifications on the path to cancer. Protein Cell. 2022;13(12):877–919. doi: 10.1007/s13238-021-00846-7.
  • Zhang Y, Sun Z, Jia J, et al. Overview of histone modification. Adv Exp Med Biol. 2021;1283:1–16.
  • Qin YP, Yu HB, Yuan SY, et al. KAT2A promotes hepatitis B virus transcription and replication through epigenetic regulation of cccDNA minichromosome. Front Microbiol. 2021;12:795388. doi: 10.3389/fmicb.2021.795388.
  • Tong Y, Guo D, Yan D, et al. KAT2A succinyltransferase activity-mediated 14-3-3ζ upregulation promotes β-catenin stabilization-dependent glycolysis and proliferation of pancreatic carcinoma cells. Cancer Lett. 2020;469:1–10. doi: 10.1016/j.canlet.2019.09.015.
  • Wang Y, Chen W, Lian J, et al. The lncRNA PVT1 regulates nasopharyngeal carcinoma cell proliferation via activating the KAT2A acetyltransferase and stabilizing HIF-1α. Cell Death Differ. 2020;27(2):695–710. doi: 10.1038/s41418-019-0381-y.
  • Grant PA, Duggan L, Côté J, et al. Yeast Gcn5 functions in two multisubunit complexes to acetylate nucleosomal histones: characterization of an Ada complex and the Saga (Spt/Ada) complex. Genes Dev. 1997;11(13):1640–1650. doi: 10.1101/gad.11.13.1640.
  • Wang L, Dent SY. Functions of Saga in development and disease. Epigenomics. 2014;6(3):329–339. doi: 10.2217/epi.14.22.
  • Wang Y, Guo YR, Liu K, et al. KAT2A coupled with the α-KGDH complex acts as a histone H3 succinyltransferase. Nature. 2017;552(7684):273–277. doi: 10.1038/nature25003.
  • Lu D, Song Y, Yu Y, et al. KAT2A-mediated AR translocation into nucleus promotes abiraterone-resistance in castration-resistant prostate cancer. Cell Death Dis. 2021;12(8):787. doi: 10.1038/s41419-021-04077-w.
  • Han X, Chen J. KAT2A affects tumor metabolic reprogramming in Colon cancer progression through epigenetic activation of E2F1. Hum Cell. 2022;35(4):1140–1158. doi: 10.1007/s13577-022-00707-3.
  • Lin S, Qiu L, Liang K, et al. KAT2A/E2F1 promotes cell proliferation and migration via upregulating the expression of UBE2C in pan-cancer. Genes (Basel). 2022;13(10):1817. doi: 10.3390/genes13101817.
  • Li J, Cao F, Yin HL, et al. Ferroptosis: past, present and future. Cell Death Dis. 2020;11(2):88. doi: 10.1038/s41419-020-2298-2.
  • Guo J, Xu B, Han Q, et al. Ferroptosis: a novel anti-tumor action for cisplatin. Cancer Res Treat. 2018;50(2):445–460. doi: 10.4143/crt.2016.572.
  • Yang WS, SriRamaratnam R, Welsch ME, et al. Regulation of ferroptotic cancer cell death by GPX4. Cell. 2014;156(1-2):317–331. doi: 10.1016/j.cell.2013.12.010.
  • Zhang W, Gong M, Zhang W, et al. Thiostrepton induces ferroptosis in pancreatic cancer cells through STAT3/GPX4 signalling [published correction appears in cell death dis. 2022 sep 14;13(9):789]. Cell Death Dis. 2022;13(7):630. doi: 10.1038/s41419-022-05082-3.
  • Liu W, Chakraborty B, Safi R, et al. Dysregulated cholesterol homeostasis results in resistance to ferroptosis increasing tumorigenicity and metastasis in cancer. Nat Commun. 2021;12(1):5103. doi: 10.1038/s41467-021-25354-4.
  • Wu J, Minikes AM, Gao M, et al. Intercellular interaction dictates cancer cell ferroptosis via NF2-YAP signalling [published correction appears in nature. 2019 aug 2;:]. Nature. 2019;572(7769):402–406. doi: 10.1038/s41586-019-1426-6.
  • Ouyang S, Li H, Lou L, et al. Inhibition of STAT3-ferroptosis negative regulatory axis suppresses tumor growth and alleviates chemoresistance in gastric cancer. Redox Biol. 2022;52:102317. doi: 10.1016/j.redox.2022.102317.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.